A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

1. Serruys, P.W.
2. Chevalier, B.
3. Dudek, D.
4. Cequier, A.
5. Carrié, D.
6. Iniguez, A.
7. Dominici, M.
8. Van Der Schaaf, R.J.
9. Haude, M.
10. Wasungu, L.
11. Veldhof, S.
12. Peng, L.
13. Staehr, P.
14. Grundeken, M.J.
15. Ishibashi, Y.
16. Garcia-Garcia, H.M.
17. Onuma, Y.